Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schellhammer

Showing results (31-40 of 326) with videos related to

Pageof 33
Sort By:
Expert Opinion on Pharmacotherapy|August 21, 2002
An evaluation of bicalutamide in the treatment of prostate cancerPaul F Schellhammer
The Journal of Urology|November 21, 2002
Re: Trends in Gleason score for prostate cancer diagnosed between 1983 and 1993Paul F Schellhammer
The Journal of Urology|November 1, 1973
Renal failure associated with the use of thio-tepaP F Schellhammer
The Journal of Urology|February 9, 2026
Letter: Shared Decision-Making in Prostate Cancer Management: Easy to Say, Hard to MeasurePaul F Schellhammer
The Journal of Urology|January 1, 1984
Re: Prostatorectal fistula associated with 125iodine seed radiotherapyP F Schellhammer
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer: will more prove better?P F Schellhammer
Urology|December 31, 1997
Fulminant hepatic failure associated with bicalutamideP F Schellhammer
The Journal of Urology|May 18, 2007
Re: choices. M. I. Resnick J Urol 2006; 176: 2342Paul F Schellhammer
Urology|January 1, 1991
BCG treatment of superficial transitional cell carcinomaP F Schellhammer
European Urology|July 17, 2009
Words of wisdom. Re: Pathologic characteristics of cancers detected in the Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemopreventionPaul F Schellhammer
Pageof 33

Showing results (31-40 of 326) with videos related to

Sort By:
Pageof 33
Expert Opinion on Pharmacotherapy|August 21, 2002
An evaluation of bicalutamide in the treatment of prostate cancerPaul F Schellhammer
The Journal of Urology|November 21, 2002
Re: Trends in Gleason score for prostate cancer diagnosed between 1983 and 1993Paul F Schellhammer
The Journal of Urology|November 1, 1973
Renal failure associated with the use of thio-tepaP F Schellhammer
The Journal of Urology|February 9, 2026
Letter: Shared Decision-Making in Prostate Cancer Management: Easy to Say, Hard to MeasurePaul F Schellhammer
The Journal of Urology|January 1, 1984
Re: Prostatorectal fistula associated with 125iodine seed radiotherapyP F Schellhammer
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer: will more prove better?P F Schellhammer
Urology|December 31, 1997
Fulminant hepatic failure associated with bicalutamideP F Schellhammer
The Journal of Urology|May 18, 2007
Re: choices. M. I. Resnick J Urol 2006; 176: 2342Paul F Schellhammer
Urology|January 1, 1991
BCG treatment of superficial transitional cell carcinomaP F Schellhammer
European Urology|July 17, 2009
Words of wisdom. Re: Pathologic characteristics of cancers detected in the Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemopreventionPaul F Schellhammer
Pageof 33